Jeffrey Allen Bailey

CIK: 0001500210

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AUPH

Aurinia Pharmaceuticals Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AUPH
Aurinia Pharmaceuticals Inc.
Jun 4, 2026
Award(A)
Director Stock Option (right to buy)
Direct
23.9K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Nov 21, 2025
Tax Payment(F)
Direct
2.7K shares at avg. $15.68$43K
AUPH
Aurinia Pharmaceuticals Inc.
May 16, 2025
Award(A)
Director Stock Option (right to buy)
Direct
37.5K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Nov 21, 2024
Award(A)
Direct
12.1K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Nov 11, 2024
Sale(S)
Direct
4.6K shares at avg. $8.43$38K
AUPH
Aurinia Pharmaceuticals Inc.
Nov 8, 2024
Exercise(M)
Direct
17.9K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	23,931	-	-	Direct
Nov 21, 2025	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	2,716	$15.68	$42,587	Direct
May 16, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A) Director Stock Option (right to buy)	37,485	-	-	Direct
Nov 21, 2024	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	12,135	-	$0	Direct
Nov 11, 2024	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	4,557	$8.43	$38,416	Direct
Nov 8, 2024	AUPH Aurinia Pharmaceuticals Inc.	Exercise(M)	17,913	-	$0	Direct

1-6 of 6 transactions

About Bailey Jeffrey Allen

Bailey Jeffrey Allen (SEC CIK 0001500210) files insider reports with the SEC as Director of Aurinia Pharmaceuticals Inc. (AUPH).

Signal8 holds 5 ownership filings by Bailey Jeffrey Allen, all Form 4s, filed between Nov 12, 2024 and Jun 8, 2026. Those filings report 6 transactions, from Nov 8, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bailey Jeffrey Allen's filings is in EDMONTON.

Recent filings by Bailey Jeffrey Allen

Jun 4, 2026: Grant or award of AUPH derivative securities (Form 4, code A).
Nov 21, 2025: Tax withholding of AUPH shares (Form 4, code F).
May 16, 2025: Grant or award of AUPH derivative securities (Form 4, code A).
Nov 21, 2024: Grant or award of AUPH shares (Form 4, code A).
Nov 11, 2024: Open-market sale of AUPH shares (Form 4, code S).

Other insiders filing for Aurinia Pharmaceuticals Inc. (AUPH)

Robertson Stephen P., Chief Legal Officer
Johnson Craig A, Director
Goetz Kathleen, Director
Nova Tina Susan, Director
TANG KEVIN, Chief Executive Officer
Hearne Michael S, Chief Financial Officer

How to read Form 4 transaction codes